• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards | Inspections
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameMULTI-STRATEGY COCHLEAR IMPLANT-PLATINUM BTE SOUND PROCESSOR (ADULT)
Classification Nameimplant, cochlear
Generic Namecochlear implant (adult)
ApplicantADVANCED BIONICS CORP.
PMA NumberP940022
Supplement NumberS016
Date Received11/16/2000
Decision Date01/12/2001
Product Code
MCM[ Registered Establishments with MCM ]
Advisory Committee Ear Nose & Throat
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications - component
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for incorporation of the size-reduced speech processor to be worn behind the ear, known as the platinum bte(tm) sound processor. The device, as modified, will be marketed under the trade name clarion(r) multi-strategy cochlear implant platinum bte sound processor. The device is indicated to restore a level of auditory sensation to individuals with profound sensorineural deafness via electrical stimulation of the auditory nerve. Adults: 1) 18 years of age or older 2) profound, bilateral sensorineural deafness (>=90db) 3) postlingually deafened 4) lack of benefit from appropriately fitted hearing aids.
-
-